The role of adjuvant chemotherapy in children and adolescents with surgically resected, high-risk adult-type soft tissue sarcomas

Pediatric Blood and Cancer

Volumn 45, Issue 2, 2005, Pages 128-134

  Ferrari, Andrea ^a   Brecht, Ines B ^b   Koscielniak, Ewa ^b   Casanova, Michela ^a   Scagnellato, Angela ^c   Bisogno, Gianni ^c   Alaggio, Rita ^c   Cecchetto, Giovanni ^c   Catania, Serena ^a   Meazza, Cristina ^a   Int Veen, Christoph ^b   Kirsch, Sylvia ^b   Dantonello, Tobias ^b   Carli, Modesto ^c   Treuner, Joern ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b Olgahospital ^*  (Germany)

^c UNIVERSITY OF PADOVA   (Italy)

Author keywords

Adjuvant chemotherapy; Adult type soft tissue sarcomas; Non rhabdomyosarcoma soft tissue sarcomas; Pediatric soft tissue sarcomas

Indexed keywords

CARBOPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER SIZE; CANCER SURGERY; CHILD; CLEAR CELL SARCOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DATA BASE; FEMALE; GERMANY; HIGH RISK PATIENT; HUMAN; ITALY; LEIOMYOSARCOMA; LIMB TUMOR; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; SOFT TISSUE SARCOMA; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; ITALY; MALE; SARCOMA; SOFT TISSUE NEOPLASMS; SURVIVAL RATE;

EID: 22244438918     PISSN: 15455009     EISSN: None     Source Type: Journal    
DOI: 10.1002/pbc.20376     Document Type: Article

References (27)

1. Miser JS, Pappo AS, Triche TJ. et al. Other soft tissue sarcomas of childhood. In: Pizzo PA, Poplack DG, editors. Principles and practice of pediatric oncology. Philadelphia, PA: Lippincott Williams & Wilkins; 2002. pp 1017-1050.
2. Okcu MF, Munsell M, Treuner J. et al. Synovial sarcoma of childhood and adolescence: A multicenter, multivariate analysis of outcome. J Clin Oncol 2003;21:1602-1611.
3. Ferrari A, Gronchi A, Casanova M. et al. Synovial sarcoma: A retrospective analysis of 271 patients of all ages treated at a single institution. Cancer 2004;101:627-634.
4. Ferrari A, Casanova M, Meazza C. et al. Adult-type soft tissue sarcomas in pediatric age: Experience at the Istituto Nazionale Tumori in Milan. J Clin Oncol 2005; (in press).
5. Raney B, Parham D, Sommelet-Olive D. et al. Summary of the International Symposium on childhood non-rhabdomyosarcoma soft-tissue sarcomas, Padua, Italy, February 10-12, 1994. Med Pediatr Oncol 1996;26:425-430.
6. Maurer HM, Beltangady M, Gehan EA. et al. The Intergroup Rhabdomyosarcoma Study I: A final report. Cancer 1988;61:209-220.
7. Parham DM, Webber BL, Jenkins JJ. et al. Nonrahbdomyosarcomatous soft tissue sarcomas of childhood: Formulation of a simplified system for grading. Mod Pathol 1995;8:705-710.
8. Harmer MH. TNM classification of pediatric tumors. Geneva, Switzerland: UICC International Union Against Cancer; 1982. pp 23-28.
9. Enneking WF. Staging of musculoskeletal neoplasms. In: Uhtoff H, editor. Current concepts of diagnosis and treatment of bone and soft tissue tumors. Heidelberg: Springer-Verlag; 1984.
10. Kaplan E, Meier P. Non-parametric estimation from incomplete observation. J Am Stat Assoc 1958;53:457-481.
11. Sarcoma Meta-analysis Collaboration: Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults. Meta-analysis of individual data. Lancet 1997;350:1647-1654.
12. Sarcoma Meta-analysis Collaboration (SMAC): Adjuvant chemotherapy for localised soft-tissue sarcoma in adults (cochrane review). Oxford, United Kingdom: The Cochrane Library, Update Software; 2003.
13. Frustaci S, Gherlinzoni F, De Paoli A. et al. Adjuvant chemotherapy for adult soft tissue sarcomas of extremities and girdles: Results of the Italian randomized cooperative trial. J Clin Oncol 2001;19:1238-1247.
14. Bramwell VHC. Adjuvant chemotherapy for adult soft tissue sarcoma: Is there a standard of care? J Clin Oncol 2001;19:1235-1237. (Editorial)
15. Demetri G.D. Highlights of sarcoma research. J Clin Oncol Classic Pap and Curr Comments 2002;7:681-684.
16. Edmonson JH, Ryan LM, Blum RH. et al. Randomized comparison of doxorubicin alone versus ifosfamide plus doxorubicin or mitomycin, doxorubicin, and cisplatin against advanced soft tissue sarcomas. J Clin Oncol 1993;11:1269-1275.
17. Bramwell V, Rouesse J, Steward W. et al. Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: A study on the European Organization for Research and Treatment of Cancer Soft Tissue Sarcoma and Bone Sarcoma Group. J Clin Oncol 1994;12:1137-1149.
18. Alvegard TA, Sigurdsson H, Mouridsen H. et al. Adjuvant chemotherapy with doxorubicin in high grade soft tissue sarcoma: A randomized trial of the Scandinavian Sarcoma Group. J Clin Oncol 1989;7:1504-1513.
19. Antman K, Crowley J, Balcerzak SP. et al. An intergroup phase III randomized study of doxorubicin and dacarbazine with or without ifosfamide and mesna in advanced soft tissue and bone sarcomas. J Clin Oncol 1993;11:1276-1285.
20. Cormier JN, Huang X, Xing Y. et al. Cohort analysis of patients with localized, high-risk, extremity soft tissue sarcoma treated at two cancer centers: Chemotherapy-associated outcomes. J Clin Oncol 2004;22:4567-4574.
21. Pratt CB, Pappo AS, Gieser P. et al. Role of adjuvant chemotherapy in the treatment of surgically resected pediatric nonrhabdomyosarcomatous soft tissue sarcomas: A Pediatric Oncology Group Study. J Clin Oncol 1999;17:1219-1226.
22. Rao BN. Nonrhabdomyosarcoma in children: Prognostic factors influencing survival. Semin Surg Oncol 1993;9:524-531.
23. McGrory JE, Pritchard DJ, Arndt CA. et al. Nonrhabdomyosarcoma soft tissue sarcomas in children: The Mayo Clinic experience. Clin Orthop 2000;374:247-258.
24. Spunt SL, Poquette CA, Hurt YS. et al. Prognostic factors for children and adolscents with surgically resected nonrhabdomyosarcoma soft tissue sarcoma: An analysis of 121 patients treated at St. Jude Children's Research Hospital. J Clin Oncol 1999;17:3697-3705.
25. Spunt SL, Ashley Hill D, Motosue AM. et al. Clinical features and outcome of initially unresected nonmetastatic pediatric nonrhaddomyosarcoma soft tissue sarcoma. J Clin Oncol 2002;20:3225-3235.
26. Walter AW, Shearer PD, Pappo AS. et al. A pilot study of vincristine, ifosfamide, and doxorubicin in the treatment of pediatric non-rhabdomyosarcoma soft tissue sarcomas. Med Pediatr Oncol 1998;30:210-216.
27. Pratt CB, Maurer HM, Gieser P. et al. Treatment of unresectable or metastatic pediatric soft tissue sarcomas with surgery, irradiation, and chemotherapy: A Pediatric Oncology Group Study. Med Pediatr Oncol 1998;30:201-209.